CKW Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

CKW Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,650	Closed	-$168K	–	180
2016 Q3	$168K	Buy	+3,650	New	+$190K	0.06%	29
2015 Q3	–	Sell	-798	Closed	-$47K	–	279
2015 Q2	$47K	Hold	798	–	–	0.02%	118
2015 Q1	$50K	Buy	798 +52	+7%	+$3.02K	0.02%	114
2014 Q4	$43K	Buy	746 +113	+18%	+$6.3K	0.02%	118
2014 Q3	$34K	Buy	633 +274	+76%	+$14.5K	0.01%	141
2014 Q2	$19K	Buy	+359	New	+$18.3K	0.01%	226

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

CKW Financial Group's TEVA Position: Q4 2016 in Review

CKW Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 3,650 shares — an estimated $168K sold.

CKW Financial Group first reported a position in TEVA in Q2 2014 and held it in 6 quarters. The position peaked at $168K in Q3 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

CKW Financial Group reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
CKW Financial Group sold 3,650 Teva Pharmaceuticals shares in Q4 2016, an estimated $168K.
CKW Financial Group first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 6 quarters.
CKW Financial Group's Teva Pharmaceuticals position peaked at $168K in Q3 2016.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on CKW Financial Group's 13F filing for Q4 2016, filed 26 Jan 2017.